A phase I study of rhizoxin (NSC 332598) by 72-hour...

A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors

Tolcher, A. W., Aylesworth, C., Rizzo, J., Izbicka, E., Campbell, E., Kuhn, J., Weiss, G., Von Hoff, D. D., Rowinsky, E. K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Journal:
Annals of Oncology
DOI:
10.1023/a:1008398725442
Date:
March, 2000
File:
PDF, 607 KB
2000
Conversion to is in progress
Conversion to is failed